Skip to main content
Figure 3 | Journal of Translational Medicine

Figure 3

From: Long-term fenofibrate treatment impaired glucose-stimulated insulin secretion and up-regulated pancreatic NF-kappa B and iNOS expression in monosodium glutamate-induced obese rats: Is that a latent disadvantage?

Figure 3

Fenofibrate affects insulin secretion in obese MSG rats. Pancreatic beta cell function was evaluated by hyperglycemic clamp. After sampling (t = 0 min) for the assay of the basal blood glucose and insulin, animals received intravenously a glucose bolus followed by a constant infusion of glucose to maintain plasma glucose level at 14 mmol/l. (A) Plasma glucose level, (B) Glucose infusion rates (GIR), (C) Plasma insulin level, and (D) Insulin stimulation ratio. Nor, normal rats. Con, water treated obese MSG rats. Fen, fenofibrate treated obese MSG rats. Values represented means ± s.e.m. (n = 6-8). *p < 0.05, **p < 0.01, ***p < 0.001 vs. control.

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us